|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/12 | |
| C07K 14/50 | |||
| C12N 15/62 | |||
| C07K 16/18 | |||
| G01N 33/53 | |||
| A61K 38/18 | |||
| A61K 31/70 | |||
| A01K 67/027 |
| (11) | Number of the document | 1214409 |
| (13) | Kind of document | T |
| (96) | European patent application number | 00917878.1 |
| Date of filing the European patent application | 2000-03-09 | |
| (97) | Date of publication of the European application | 2002-06-19 |
| (45) | Date of publication and mention of the grant of the patent | 2006-05-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2000/006471 |
| Date | 2000-03-09 |
| (87) | Number | WO 2001/018210 |
| Date | 2001-03-15 |
| (30) | Number | Date | Country code |
| PCT/US99/20594 | 1999-09-08 | WO | |
| PCT/US99/21090 | 1999-09-15 | WO | |
| PCT/US99/30999 | 1999-12-20 | WO | |
| PCT/US00/04414 | 2000-02-22 | WO |
| (72) |
STEWART, Timothy, A., US
TOMLINSON, Elizabeth, US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco CA 94080-4990,
US
|
| (54) | FIBROBLAST GROWTH FACTOR-19 (FGF-19) NUCLEIC ACIDS AND POLYPEPTIDES AND METHODS OF USE FOR THE TREATMENT OF OBESITY |
| FIBROBLAST GROWTH FACTOR-19 (FGF-19) NUCLEIC ACIDS AND POLYPEPTIDES AND METHODS OF USE FOR THE TREATMENT OF OBESITY |